Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

News snapshot: Greenbank Capital, Talon Metals, Revive Therapeutics, Predictmedix, Doubleview Gold, Willow Biosciences UPDATE...

Québec Nickel Corp (CSE:QNI, OTCQB:QNICF) announced that it has drilled more than 250 metres (m) of serpentinized ultramafic rock at its Ducros project in Quebec, saying the results suggest the presence of large tonnage nickel-cobalt target with a geophysical expression spanning several hundred metres in width and multiple kilometers long and is similar to surrounding high-tonnage nickel-cobalt projects in the Abitibi Greenstone Belt.

The mineral exploration company also noted that exploration work will resume at the Fortin Sill Zone, following up on 2022 drill results that included 1.44% nickel, 1.49% copper, 461 parts per million (ppm) cobalt, and 2.79 grams per tonne (g/t) platinum-palladium-gold.

Read more

Northstar Gold Corp. (CSE:NSG) said it has identified a volumetrically large positive magnetic anomaly on its flagship Miller Gold property in Ontario, thanks to an airborne magnetic survey

The anomaly in the Allied Gold zone of the property shows signs of high magnetic susceptibility, which could mean more sources for gold-copper mineralization. In fact, 11 additional anomalies consistent with possible syenite intrusions have also been identified.

Read more

Predictmedix Inc. (CSE:PMED, OTCQB:PMEDF) has said new artificial intelligence (AI)-powered screening technology will make its Safe Entry stations able to read blood pressure, adding to its existing ability to screen individuals’ temperature, heart rate, respiratory rate, and oxygen saturation.

"Monitoring blood pressure is an essential aspect of maintaining good health. Adding this feature to Safe Entry will be a significant development in the healthcare industry," Dr Rahul Kushwah, chief operations officer at Predictmedix, said in a statement.

Read more

Here Futura Medical PLC (AIM:FUM, OTC:FAMDF) CEO James Barder discusses the UK launch of Eroxon, the company's over-the-counter erectile dysfunction treatment, with Thomas Warner of Proactive.

Eroxon is now available at Boots stores and online. Barder highlighted the importance of respecting commercial partners' wishes, noting that updates will be provided reactively rather than proactively.

Read more

Primary Health Properties PLC (LSE:PHP, OTC:PHPRF) (PHP) has reported 0.9% growth from its rent review and asset management activities in the first-quarter of 2023, generating an extra £1.3mln on a like-for-like basis compared to the first quarter of 2021.

In a trading update. the modern healthcare facilities investor said settled rent reviews generated £1.2mln, primarily driven by the impact of inflation on both indexed-linked and open market value (OMV) reviews, while asset management activities generated an additional £100,000, with three new projects due to start shortly.

Read more

Faron Pharmaceuticals Limited (AIM:FARN, OTC:FPHAF) has announced plans to host a virtual event via webcast on Tuesday, 25 April, to discuss its progress in developing novel immunotherapies for the treatment of cancers.

The event will feature Dr Naval Daver, associate professor of Leukemia at The University of Texas MD Anderson Cancer Center, and Dr Mika Kontro, associate professor at the University of Helsinki, who will provide an update on the most recent Phase I/II BEXMAB data in AML and MDS patients.

Read more

Atlantic Lithium Limited (AIM:ALL, OTCQX:ALLIF, ASX:A11) has started infill programmes at Ewoyaa in Ghana comprising 3,000 metres (m) of reverse circulation and diamond drilling with a passive seismic survey also underway.

Lennard Kolff, interim chief executive, said the exploration aims to de-risk the project's current resources further and add optionality to the mine plan.

Read more

ANGLE PLC (AIM:AGL, OTCQX:ANPCY), the liquid biopsy company, has announced a partnership with BioView, a developer and marketer of automated cell imaging and analysis solutions, to create a circulating tumour cell (CTC) HER2 assay for breast cancer.

The test will utilise ANGLE's FDA-cleared Parsortix PC1 Clinical System and BioView's automated microscopy systems and software, and is expected to generate around £1.2mln in revenues for the London-listed group.

Read more

Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF) has announced a significant milestone in its innovative peanut allergy treatment with the successful completion of skin-prick testing on peanut-allergic patients in the phase I PROTECT clinical trial.

The results indicate a substantial reduction in skin reactivity for the company's VLP Peanut vaccine compared to standard peanut extract.

Read more

ImmuPharma PLC (AIM:IMM, OTC:IMMPF) has confirmed a Type-C meeting is scheduled with the US Food and Drug Administration (FDA) for 7 June.

Scientists will discuss the upcoming phase II/III adaptive study of Lupuzor (also known as P140) in systemic lupus erythematosus patients. This development follows the company's recent announcement on 27 March 2023.

Read more

Anteris Technologies Ltd (ASX:AVR, OTC:AMEUF) has formed a partnership with v2vmedtech, Inc. to create a novel heart valve repair device for minimally invasive treatment of mitral and tricuspid valve regurgitation, also known as a leaky valve.

This cutting-edge technology is a valuable addition to Anteris' portfolio, allowing the company to expand into a market adjacent to transcatheter aortic valve replacement (TAVR) - a market expected to reach A$4.1 billion by 2028.

Read more

One of the world’s largest graphene-enhanced green cement trials is set to start in June as First Graphene Ltd (ASX:FGR, OTCQB:FGPHF) leads a consortium to investigate a simple, low-cost method of introducing graphene to industrial-scale cement processes.

“Our research and development in collaboration with some of the world’s most innovative materials technology organisations, coupled with buy-in from industry partners to trial our graphene products, sets the foundation for a strong commercialisation pathway,” First Graphene managing director and CEO Michael Bell said.

Read more

Ximen Mining Corp said it has received the Final Mines Act Permit for its Kenville Gold Mine project in southeastern British Columbia. "The Kenville Gold Mine, which began operations in 1888, was one of the first underground gold mines in British Columbia. After years of working on this particular permit, the Kenville Gold Mine is now on track to becoming one of the greenest and environmentally-friendly gold mines in Southern BC. While there is still very much to do, our team's tenacity has brought us this far, and we are ready for the next phase of milestones that will finally bring this gold mine to fruition,” noted Christopher R. Anderson, CEO of Ximen Mining.

Steppe Gold Ltd has announced the extension of the binding letter of intent dated March 6, 2023, under which Steppe Gold, either directly or through a wholly-owned subsidiary, will acquire all of the issued and outstanding common shares of Anacortes by way of a court approved plan of arrangement under the Business Corporations Act (British Columbia), in an all-share transaction. The extension extends the exclusivity period between Steppe Gold and Anacortes in the agreement from April 17, 2023 to May 5, 2023, or such earlier or later time as Steppe Gold and Anacortes mutually agree, in order to provide more time for the parties to complete due diligence and enter into a definitive agreement.

Hawkmoon Resources Corp has changed its name to Earthwise Minerals Corp to highlight the company's commitment to sustainable resource development and exploration. The trading symbol under which the company's common shares trade will also be changing from HM to WISE. The company expects its common shares to begin trading under the new name and symbol on or about April 21, 2023.

Plurilock Security Inc said it has signed a contract renewal for its flagship software platform with an overseas developer of integrated resorts. The customer develops and operates integrated resorts, which primarily include tourist-focused hotels and gaming facilities. The platform will be utilized by over 1.900 users. “We are pleased to announce a contract renewal with an overseas customer,” said Ian L. Paterson, CEO of Plurilock. “This contract renewal highlights our ongoing efforts to secure and retain customers globally for our high-margin software solutions. Overall, we aim to maintain strong business relationships with existing customers and help them protect their employees with our zero-trust technology offerings.”

Valeo Pharma Inc CEO Steve Saviuk will present a corporate overview and provide a commercial update on key products of the company at the 2023 Bloom Burton & Co Healthcare Investor Conference on Tuesday, April 25, 2023 at 11.00am ET. A live webcast of the presentation may be accessed via https://wsw.com/webcast/bloomburton8/vph/2543354 and on the Webcast & Events page under the Investors section of the company’s website at Events - Valeo Pharma. Following the event, an archived webcast will be available on the company’s website.

Wishpond Technologies Ltd has said it will be presenting at the Planet MicroCap Showcase: VEGAS 2023 investor conference taking place at the Horseshoe Hotel & Casino in Las Vegas, Nevada on April 26 and 27. Wishpond chairman and CEO, Ali Tajskandar, will be providing a live presentation at 11.30am PT (2.30pm ET) on Wednesday, April 26, 2023, where he will discuss the company's business strategy and growth outlook. To access the live presentation, interested parties can use the following webcast link: https://www.webcaster4.com/Webcast/Page/2963/47992. Wishpond will also be conducting in-person 1x1 meetings at the conference venue.

Golden Shield Resources Inc granted 2.25 million incentive stock options to employees, officers, directors and consultants of the company. The options are exercisable at a price of $0.26, have a term of five years, and will vest over a period of 36 months. The resource firm also said it has hired Thesis Marketing Inc to provide marketing services through social media channels and digital ads for a term of six months to commence on May 1, 2023, in consideration of a payment of C$40,000 plus applicable taxes.

MySize Inc CEO Ronen Luzon will present at the Sequire Investor Summit in Puerto Rico on Tuesday, April 25 at 11:30 am AT/10:30 am ET. For more information about the Sequire Investor Summit, including registration details, please visit the official event website at https://puertorico.srax.com/.

Information Services Corporation will release its 1Q financial results on Wednesday, May 3, 2023 after market close. It will hold an investor conference call on Thursday, May 4, 2023 at 11:00 a.m. ET to discuss the results. A live audio webcast will be available on ISC’s website at www.company.isc.ca/investor-relations/events. Participants who wish to ask a question on the live call may do so through the ISC website, or by registering at: https://register.vevent.com/register/BIe54535f2442f41678c099c31dd2ef376.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK